July 10, 2020 / 11:48 AM / a month ago

BRIEF-Oragenics Provides Update On COVID-19 Program

July 10 (Reuters) - Oragenics Inc:

* ORAGENICS PROVIDES UPDATE ON SARS-COV-2 (COVID-19) PROGRAM

* ORAGENICS INC - TERMINATES AG013 ORAL MUCOSITIS DEVELOPMENT PROGRAM

* ORAGENICS INC - EXPECT TO USE AVAILABLE CASH TO CONTINUE DEVELOPMENT OF TERRACOV2

* ORAGENICS INC - GOAL OF BRINGING COVID-19 VACCINE CANDIDATE INTO HUMAN CLINICAL TRIALS BY EARLY 2021

* ORAGENICS INC - ON JULY 9 PRECIGEN, MUTUALLY AGREED TO TERMINATE EXCLUSIVE CHANNEL COLLABORATION AGREEMENT FOR AG013 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below